Polycystic ovary syndrome: is the cardiometabolic risk increased after menopause?
Menopause
; 26(3): 331-333, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30649087
ABSTRACT
Although more commonly known for its fertility sequelae, dermatologic, metabolic, and psychological morbidities associated with polycystic ovary syndrome (PCOS) are not well recognized. This Practice Pearl reviews the effect of PCOS on cardiometabolic risk during the reproductive years and the consequence of these findings in middle-aged women. Current screening and management recommendations are reviewed.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polycystic Ovary Syndrome
/
Menopause
Type of study:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Menopause
Journal subject:
GINECOLOGIA
Year:
2019
Document type:
Article